Showing results (1-10 of 8,240) with videos related to
Sort By:
Pageof 824
Current Opinion in Genetics & Development|November 26, 2009
Scaffold-based design of kinase inhibitors for cancer therapyChao Zhang, Gideon BollagCancer Discovery|April 5, 2017
Anaphase-Promoting Complex Adaptor FZR1/CDH1 Blocks BRAF Signaling Both by Targeting BRAF for Proteolytic Degradation and by Disrupting BRAF DimerizationChao Zhang, Gideon BollagCurrent Topics in Microbiology and Immunology|August 3, 2011
Setting up a kinase discovery and development projectGideon BollagNature|February 25, 2010
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAFPoulikos I Poulikakos, Chao Zhang, Gideon Bollag, et al.Nature Reviews. Drug Discovery|October 13, 2012
Vemurafenib: the first drug approved for BRAF-mutant cancerGideon Bollag, James Tsai, Jiazhong Zhang, et al.Cancer Research|January 16, 2026
Overcoming the Limits of Inhibition: Mutant-Selective BRAF DegradersPan-Yu Chen, Gideon BollagNature Reviews. Cancer|March 27, 2007
Hyperactive Ras in developmental disorders and cancerSuzanne Schubbert, Kevin Shannon, Gideon BollagCurrent Opinion in Genetics & Development|January 9, 2007
Deregulated Ras signaling in developmental disorders: new tricks for an old dogSuzanne Schubbert, Gideon Bollag, Kevin ShannonCurrent Opinion in Investigational Drugs (London, England : 2000)|February 7, 2004
Raf pathway inhibitors in oncologyGideon Bollag, Scott Freeman, John F Lyons, et al.Pageof 824